Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mouwasat Medical Services CoSAU:4002 -1.63%97 Return-on-Tangible-Asset is 12.95% as of Mar. 2026, which is 6% below its 10-year median of 13.81. GuruFocus rates SAU:4002 with a GF Score™ of 97/100 and a GF Value™ of ﷼109.31 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 680 Healthcare Providers & Services companies, Mouwasat Medical Services Co ranks better than 89.71% on this metric.
The historical rank and industry rank for Mouwasat Medical Services Co's Return-on-Tangible-Asset or its related term are showing as below:
SAU:4002'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 12.55 Med: 13.81 Max: 15.29
Current: 14.04
During the past 13 years, Mouwasat Medical Services Co's highest Return-on-Tangible-Asset was 15.29%. The lowest was 12.55%. And the median was 13.81%.
SAU:4002's Return-on-Tangible-Asset is ranked better than 89.71% of 680
companies
in the Healthcare Providers & Services industry
Industry Median: 2.705
vs SAU:4002: 14.04
Mouwasat Medical Services Co (SAU:4002) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Mouwasat Medical Services Co Return-on-Tangible-Asset Related Terms
Mouwasat Medical Services Co Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mouwasat Medical Services Co Return-on-Tangible-Asset Chart
SAU:4002 vs HCA, THC, DVA: Return-on-Tangible-Asset Comparison
For the Medical Care Facilities subindustry, Mouwasat Medical Services Co's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mouwasat Medical Services Co Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Mouwasat Medical Services Co's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Mouwasat Medical Services Co's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 12.95% mean?
Mouwasat Medical Services Co (SAU:4002) has a Return-on-Tangible-Asset of 12.95% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Mouwasat Medical Services Co and its competitors. This is near median its historical median of 13.81. Over the past decade, Mouwasat Medical Services Co's Return-on-Tangible-Asset has ranged from 12.55 to 15.29. According to the industry distribution chart, Mouwasat Medical Services Co ranks #70 out of 680 companies in the Healthcare Providers & Services industry, placing it in the top 10.3%.
Is Mouwasat Medical Services Co's Return-on-Tangible-Asset too high?
Mouwasat Medical Services Co's current Return-on-Tangible-Asset of 12.95% is near median its 10-year median of 13.81. Over the past 10 years, this metric has ranged from a low of 12.55 to a high of 15.29. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.71. Mouwasat Medical Services Co's value of 12.95% is 378.7% above this industry median. Based on the distribution chart, Mouwasat Medical Services Co ranks #70 out of 680 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Mouwasat Medical Services Co has a GF Score™ of 97/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mouwasat Medical Services Co's Return-on-Tangible-Asset compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Mouwasat Medical Services Co ranks #70 out of 680 companies for Return-on-Tangible-Asset. This places Mouwasat Medical Services Co in the top 10% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 2.71. Mouwasat Medical Services Co's value of 12.95% is 378.7% above this benchmark. Historically, Mouwasat Medical Services Co's own Return-on-Tangible-Asset has ranged from 12.55 to 15.29 over the past decade. While the company's 10-year median is 13.81 vs. the industry median of 2.71, Mouwasat Medical Services Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.71, based on 680 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mouwasat Medical Services Co's current Return-on-Tangible-Asset of 12.95% is 378.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Mouwasat Medical Services Co and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mouwasat Medical Services Co's current Return-on-Tangible-Asset is 12.95%, which is near median its own 10-year median of 13.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mouwasat Medical Services Co stock overvalued right now?
Based on GuruFocus' analysis, Mouwasat Medical Services Co (SAU:4002) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼109.31, compared to a current price of ﷼63.50 — trading 41.9% below its estimated fair value. The current Return-on-Tangible-Asset is 12.95%, which is near median its 10-year median of 13.81 and 378.7% above the Healthcare Providers & Services industry median of 2.71. Mouwasat Medical Services Co's overall GF Score™ is 97/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Mouwasat Medical Services Co (SAU:4002), the current Return-on-Tangible-Asset is 12.95% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mouwasat Medical Services Co (SAU:4002) Overvalued in 2026?
Based on GuruFocus' analysis, Mouwasat Medical Services Co stock appears to be undervalued.
The current stock price of ﷼63.50 is trading 41.9% below its estimated GF Value™ of ﷼109.31.
GuruFocus considers Mouwasat Medical Services Co to be Significantly Undervalued.
Key valuation signals for SAU:4002:
Return-on-Tangible-Asset: 12.95% (near median its 10-year median of 13.81)
GF Value™: ﷼109.31 vs. price of ﷼63.50 (41.9% below fair value)
Industry Position: 378.7% above the Healthcare Providers & Services median (#70 of 680)
No single metric tells the full story. See the SAU:4002 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mouwasat Medical Services Co is engaged in the acquisition, management, operation, and maintenance of hospitals, medical centers, drug stores, pharmacies, and wholesale of medical equipment and drugs. The company also operates skin care centers that offer clinical and cosmetic dermatology, aesthetic and reconstructive plastic surgery, weight reduction, and esthetician services. It operates in two segments Medical Services segment and Pharmaceuticals out of which the Medical Services segment derives the majority of revenue. The Medical Services segment includes Inpatient and outpatient services. The company provides specialized centers: Eye Center, Robotic Surgeries Center, Diabetes Center, Fertility Unit, Cardiology Center, Stroke Unit, Long Term Care Center, Obesity Center, and others.
97GF Score
Get the complete analysis for SAU:4002
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4002 has been successfully added to your 
